# Octapharma Plasma Inc – FDA Inspection, Oct 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/40ebaaab-ea92-4f45-bd13-9e9804ecfdc5
Source feed: FDA_Inspections

> FDA inspection 1029299 of Octapharma Plasma Inc, October 20, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029299
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2017-10-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1277356 - 2025-07-18
- FDA Inspection 1072791 - 2018-11-14
- FDA Inspection 791773 - 2012-07-12
- FDA Inspection 738369 - 2011-08-03
- FDA Inspection 681948 - 2010-09-23

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/760af2c6-841c-4e86-a773-34664a464b58

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d